Scientific Advisory Board (SAB) includes experts in the development and approved T-cell engager therapies, supporting CAPTN-3 ...

The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...

This week on "The Readout LOUD": a CAR-T biotech's dramatic turnaround, and drugmakers' tactics to drive more scripts. Listen ...

The promise of a better pan-RAS inhibitor Erasca has been described as the poor man’s Revolution Medicines. Impoverished ...

Alex Karnal, co-founder and CIO of Braidwell, a life sciences investment firm, spent 20 years building and backing biotech ...

Legend Biotech (NASDAQ: LEGN) was one of the healthier healthcare stocks on the market as the trading week kicked off on ...

But in the last three years, the company has sought to leverage its footholds in China and the U.S. to become a multinational ...

Introducing CPC Biotech - one brand uniting critical fluid management components New brand unites CPC’s Biopharma connector ...

Insiders who bought Edesa Biotech, Inc. ( NASDAQ:EDSA ) stock in the last 12 months were richly rewarded last week.

Doubling survival in pancreatic cancer, a long-fought rare disease approval, a massive IPO and ambitious biotech ...

The deal for Kelonia Therapeutics is valued at $3.25 billion upfront.

On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...